Nantahala Capital Management LLC decreased its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 7.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,435,122 shares of the company's stock after selling 115,000 shares during the quarter. Nantahala Capital Management LLC owned 3.70% of Viemed Healthcare worth $9,400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in VMD. New York State Teachers Retirement System bought a new stake in Viemed Healthcare in the 1st quarter worth approximately $29,000. Evernest Financial Advisors LLC bought a new position in shares of Viemed Healthcare during the 2nd quarter valued at approximately $66,000. Victory Capital Management Inc. increased its position in shares of Viemed Healthcare by 21.1% during the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company's stock valued at $84,000 after purchasing an additional 2,226 shares during the last quarter. Price T Rowe Associates Inc. MD bought a new position in shares of Viemed Healthcare during the 1st quarter valued at approximately $97,000. Finally, The Manufacturers Life Insurance Company increased its position in shares of Viemed Healthcare by 14.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company's stock valued at $98,000 after purchasing an additional 1,912 shares during the last quarter. Institutional investors own 74.24% of the company's stock.
Viemed Healthcare Trading Up 1.4 %
Shares of NASDAQ VMD traded up $0.10 during trading hours on Tuesday, hitting $7.43. 542,960 shares of the company traded hands, compared to its average volume of 146,238. The stock has a market capitalization of $288.51 million, a price-to-earnings ratio of 28.15 and a beta of 1.47. The company has a current ratio of 1.43, a quick ratio of 1.29 and a debt-to-equity ratio of 0.07. The company's 50 day moving average price is $7.29 and its 200 day moving average price is $7.48. Viemed Healthcare, Inc. has a 12 month low of $5.90 and a 12 month high of $10.44.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.03). The company had revenue of $54.97 million for the quarter. Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%.
Viemed Healthcare Company Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
See Also
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
